Company: Sagent Pharmaceuticals
Based: Schaumburg, IL
Investors: Capricorn Management, Vivo Ventures
Scoop: Sagent Pharmaceuticals brings finished pharmaceutical therapies onto the U.S. market; it is focused on injectable products. The company currently has more than 200 products in development, with more than 30 submissions to the FDA expected by the end of 2007. Sagent expects to double its FDA submissions in 2008.
Start-ups snare big rounds of venture funds. Report